🇺🇸 FDA
Patent

US 8241638

Induction of an immune response against dengue virus using the prime-boost approach

granted A61KA61K2039/5254A61K2039/53

Quick answer

US patent 8241638 (Induction of an immune response against dengue virus using the prime-boost approach) held by United States of America as represented by the Secretary of the Air Force expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/5254, A61K2039/53, A61K2039/545, A61K2039/70